All posts by imreal

Reliefband Flex® Launches as Next-Generation, Water-Resistant Wearable That Offers Two Weeks of Uninterrupted Nausea Relief


Reliefband Flex

“Today, everybody is living a hybrid life, doing more and accomplishing many tasks in the span of a day. Reliefband Flex helps those who suffer from nausea live their full lives without interruption,” explained Rich Ransom, President, and CEO, at Reliefband.

Reliefband®, an innovator in wearable technology that prevents and treats nausea and vomiting, has released Reliefband Flex®, the newest addition to the company’s line of FDA-cleared, anti-nausea wearables.

Available now, the water-resistant Reliefband Flex is powered by easily replaceable lithium coin batteries and delivers over 350 hours of use — doubling the usable hours offered by the Reliefband Classic®. The Reliefband Flex joins the family of wearable Reliefband devices to deliver all-natural, drug-free prevention and treatment of nausea and vomiting associated with motion sickness, morning sickness during pregnancy, chemotherapy, anxiety, hangovers, physician-diagnosed migraines, and as an adjunct to antiemetics in treating post-operative nausea.

The Reliefband Flex comes standard with the company’s popular Flex-Fit comfort band. Using available interchangeable bands and smart watch connectors, Reliefband Flex can also be seamlessly attached to an Apple or Samsung smart watch. This permits an Apple or Samsung smart watch to be worn on top of a user’s wrist while the Reliefband Flex is situated on the underside of the wrist allowing users to have the smartwatch benefits they regularly enjoy, along with continuous anti-nausea relief in one wearable device.

“Today, everybody is living a hybrid life, doing more and accomplishing many tasks in the span of a day. Reliefband Flex helps those who suffer from nausea live their full lives without interruption,” explained Rich Ransom, President, and CEO, at Reliefband. “In addition to extending usable hours, the Flex offers discreet styling and flexible wearability options to address the treatment needs of professionals, travelers, and anyone who needs to manage nausea,” he added.

The result of more than 20 years of clinical research, Reliefband’s FDA-cleared, patented technology uses accurately programmed pulses with a uniquely specific waveform, frequency, and intensity to stimulate the median nerve on the underside of the wrist. This precise activity uses the body’s natural neural pathways to block waves of nausea produced by the stomach. Reliefband Flex allows users to choose from five different intensity levels to customize their experience based on individual needs.

Reliefband’s drug-free therapy is highly effective and without the side effects associated with anti-nausea medicine such as drowsiness and constipation. All Reliefband devices can be used either before or after nausea and vomiting symptoms start and can be left on as long as symptoms subsist.

Reliefband Flex complements the company’s lineup of successful anti-nausea wearables, including the water-resistant Reliefband Sport®, Reliefband Classic®, Reliefband Premier®, and Reliefband 50 Hour® (an entry-level wearable that provides an economical solution for shorter-term nausea relief).

Availability and Pricing

The Reliefband Flex includes one 7.5 mL/0.25 oz. tube of necessary hypoallergenic conductivity gel and is priced at $179.99. A Flex bundle for $199.99 includes two 7.5 mL/0.25 oz. tubes of hypoallergenic conductivity gel, the consumer’s choice of Apple- or Samsung-compatible comfort band, and microfiber pouch. They are available now direct from Reliefband or can be ordered by telephone at 877-735-2263. For more information, please visit: http://www.Reliefband.com.

About Reliefband

Reliefband is a world leader in neuromodulation and wearable technology. The company’s patented, clinically proven wearable solution quickly prevents and effectively treats nausea and vomiting. Its unique, FDA-cleared neuromodulation technology was originally developed for use in hospitals and alters nerve activity through targeted delivery of gentle pulses to the underside of the wrist to “turn off” feelings of nausea and vomiting. Reliefband is a drug-free alternative that eliminates the discomfort associated with nausea and vomiting. The Reliefband wearable solution has been an industry leader for more than 20 years and is available OTC, at Reliefband.com and Amazon.com. For more information, visit http://www.Reliefband.com.

Share article on social media or email:

New White Paper From TriageLogic Helps Operators Improve the Accuracy of Medical Messages to Providers


Nonclinical operators take patient phone calls for a healthcare provider's office beneath the white paper title, "Improving the Accuracy of Medical Messages. Using Augmented Message Assistance to Screen Patient Symptoms and Messages."

…where some answering services were seeing intake errors as much as 40 percent of the time, MedMessage Assist was able to get that number down to less than 1 percent…

TriageLogic has released a white paper that shares data they’ve compiled on the accuracy of messages that answering services send to providers. They found that close to 30% of messages sent were insufficient to alert a provider of a highly urgent call, increasing provider liability and potential patient morbidity and mortality. The company demonstrates how an easy-to-use tool that leverages doctor-created augmented intelligence can dramatically improve the quality and accuracy of the messages received by the provider.

Normally, when patients call their providers, they’re first greeted by nonclinical operators, like front desk agents or call center representatives. These operators determine the reasons why patients are calling, and forward their messages to the appropriate nurses or providers for review. In many cases, triage nurses are responsible for vetting these messages and determining how urgent they are before calling patients back. When messages are inaccurate, it can potentially delay care and lead to poor health outcomes.

TriageLogic’s augmented intelligence-based module (MedMessage Assist, or MMA) reduced callback time by 50% for all calls resulting in an emergency disposition. In addition, where some answering services were seeing intake errors as much as 40 percent of the time, MedMessage Assist was able to get that number down to less than 1 percent — better than any training course has been able to provide. Plus, it only takes about 15 seconds to collect additional information.

Does this mean that nonclinical operators are no longer needed? Hardly, says Dr. Charu Raheja, CEO of TriageLogic. “The goal of MedMessage Assist has always been about making it easier for nonclinical operators to do their jobs well, not replace them. By some estimates, nonclinical staff account for half of all healthcare workers, and are shown to be vital to any practice’s care coordination. What matters is giving them the best tools to thrive in their roles, and ultimately pave the way for exceptional patient outcomes.”

So how does MedMessage work? TriageLogic explains that this module can be integrated with an existing health management system to analyze the text that nonclinical operators type while they’re listening to patient callers. MMA will then prompt operators with one or more questions for them to ask their patients when the symptoms described warrant additional information to determine their severity. In this manner, messages are as detailed as possible for providers and triage nurses to identify the urgency of each call.

“We’ve seen how well this has worked for Southern Voices,” notes Dr. Raheja, “and we’ve already received several excited inquiries from other clients who are ready to try it out with their teams.”

Part of spreading the word about MedMessage’s success includes past and future teleservice events for Dr. Ravi Raheja, CTO at TriageLogic. He previously attended the NAEO Conference in New Orleans back in March, and is currently scheduled to hold a demonstration about AI training performance with David Lawson, CEO of Call Simulator, at the 32nd Annual Conference for the Healthcare Contact Center Times (HCCT) in Atlanta this June. (Simultaneously, Dr. Raheja will be attending the ATSI Conference also held in Atlanta that week.)

Please contact TriageLogic to learn more about MedMessage Assist and how to deliver more accurate messages to your providers. Following a demonstration, this service can be up and running within a day.

About TriageLogic

TriageLogic is a URAC-accredited, physician-led provider of top-quality nurse telehealth technology, remote patient monitoring, and medical call center solutions. Founded in 2007, the TriageLogic Group now serves more than 22,000 physicians and covers over 42 million lives nationwide.

Share article on social media or email:

IV Interactive Presented With Award for Orthopedic Website Design Innovation


IV Interactive, a digital marketing agency dedicated to medical and healthcare organizations, is the 2023 Gold Award recipient, for its design of The Orthopedic Health Center website, an award-winning orthopedic practice with locations in Hoboken, Jersey City, and Bayonne, NJ.

Now in its 21st year, The Horizon Interactive Awards recognizes excellence in interactive, web, and creative media production. Judging for the Awards is done by a panel of industry professionals, with five criteria being given equal weight: UX/design, creativity, technical, message, and effectiveness.

Of the more than 20,000 worldwide entries submitted, IV Interactive was awarded Gold in the Health/Human Services category, recognizing the best websites, videos, online advertising, print media, and mobile applications in healthcare and wellness.

“Our creative team could not be prouder to have been honored for this website,“ states Dov Radzik, IV Interactive CEO. “Winning the Gold Award for Website Design means that we succeeded in our goal of providing our client with an effective, individualized showcase for patient and physician engagement.”

The website design has allowed The Orthopedic Health Center to better connect with its patients, including English and Spanish-language populations in Hudson County, Northern New Jersey, and New York City. “With the website implementation, we’ve updated our processes and streamlined how we and our patients communicate with each other,” said Dr. Edward Feliciano, Director of Orthopedic Surgery at The Orthopedic Health Center. “We’re able to offer quicker, more direct access to valuable resources, including diagnostic and treatment options, administrative matters, and a full library’s worth of information about common musculoskeletal conditions.”

“We worked closely with The Orthopedic Health Center to craft a website that conveyed the practice’s commitment to its patients,” said Radzik. “Rather than a clinical atmosphere, we presented the doctors as real people, making their patients’ lives better. This is a place where no injury is too small to expect exceptional orthopedic treatment. Whether you have a stubbed toe or a chronic spinal condition, The Orthopedic Health Center will prioritize your care.”

About The Orthopedic Health Center

The Orthopedic Health Center is a full-service orthopedic practice with three locations in Hoboken, Jersey City, and Bayonne, NJ. They specialize in providing exceptional orthopedic care for injuries as well as acute and chronic conditions. Under the direction of renowned orthopedic specialist and surgeon, Dr. Edward Feliciano, the center provides advanced, minimally invasive surgical and non-surgical solutions, including comprehensive orthopedics, sports medicine, complete spine care, and pediatric orthopedics. They diagnose and treat a host of musculoskeletal conditions, including knee pain, shoulder pain, and more. Schedule an appointment today!

About IV Interactive

IV Interactive is a full-service interactive agency specializing in the four major elements required for success in a digital world: innovative design, interactive marketing, technology implementation, and strategic consulting. Using this multidisciplinary approach, the agency provides results-driven, award-winning solutions to healthcare organizations around the world. Which elements are you missing? Visit IVInteractive.com to find out.

Share article on social media or email:

RetireeFirst CEO John Dulczak Selected as Finalist in EY Entrepreneur of the Year 2023 Greater Philadelphia Awards


John Dulczak, founder and CEO of RetireeFirst

I’m honored to be recognized for work that gives me an incredible sense of pride and satisfaction. I’m driven by my passion for providing an excellent healthcare benefits experience for our retiree clients.

Ernst & Young LLP (EY US) recently announced that John P. Dulczak, founder and CEO of RetireeFirst, was selected as a finalist in the Entrepreneur of the Year® 2023 Greater Philadelphia Awards. Now in its 37th year, Entrepreneur of the Year is one of the preeminent competitive business awards for transformative entrepreneurs and leaders of high-growth companies who are building a more equitable, sustainable and prosperous world for all.

Dulczak was selected by an independent panel of judges. Entrepreneurs were evaluated based on their demonstration of building long-term value through entrepreneurial spirit, purpose, growth and impact, among other core contributions and attributes.

“I’m honored to be recognized for work that gives me an incredible sense of pride and satisfaction. I’m driven by my passion for providing an excellent healthcare benefits experience for our retiree clients. Our focus will always be helping retirees meet their health and wellness needs while reducing costs and administrative burdens of group retiree plans,” Dulczak said. “I’m thankful to the EY Entrepreneur of the Year Awards committee for seeing the value in what we do and for taking the time to learn more about the motivation behind our company’s amazing journey.”

Founded in 2005, the company quickly made a name for itself as a valuable partner that manages every aspect of group retiree healthcare benefit administration. From plan design and selection to implementation and ongoing benefit administration, RetireeFirst creates a better experience for plan sponsors and helps improve health outcomes for retired members. Following a rebrand to RetireeFirst earlier this year, the company is building on that legacy and upholding its excellent standards.

RetireeFirst has grown significantly the last five years, and company leaders expect that momentum to continue due to the increased demand for its service and skills amid the complex and ever-evolving Medicare landscape. RetireeFirst’s services and solutions are specially designed to support plan sponsors who are challenged with managing benefits budgets and risks while ensuring retiree member needs are met. RetireeFirst Advocates truly care about helping members navigate Medicare, understand their benefits, and connect to programs that can improve their health and wellbeing. The team carries out this mission while maintaining an impressive client retention rate of 100% and achieving an annual net promoter score (NPS) above 90, a significantly higher ranking than the healthcare industry average of 58.

Dulczak and his team are looking forward to June 8, when EY regional award winners will be announced during a special celebration. The winners will then be considered by the national judges for the Entrepreneur of the Year National Awards, which will be presented in November at the annual Strategic Growth Forum® – one of the nation’s most prestigious gatherings of high-growth, market-leading companies. The Entrepreneur of the Year National Overall Award winner will then move on to compete for the EY World Entrepreneur of the Year™ Award in June 2024.

The Entrepreneur of the Year program has recognized more than 11,000 entrepreneurs throughout the US since its inception in 1986, and it has grown to recognize business leaders across 145 cities in over 60 countries around the world.

About RetireeFirst

RetireeFirst is the premier retiree benefit management solutions and advocacy service provider, proven to enhance the experience and outcomes for group plan sponsors and their retirees. Founded in 2005, the company partners with all major national health carriers and hundreds of labor unions, public sector entities, and private corporations nationwide. RetireeFirst designs solutions that preserve and enhance benefit quality while driving material cost savings. Its unparalleled advocacy service creates a seamless benefits experience and connects members to programs that improve their health and wellness. RetireeFirst is HITRUST certified and has been awarded a full URAC Core Accreditation for its commitment to upholding federal regulatory requirements and improving business processes. Headquartered in Mount Laurel, NJ, RetireeFirst’s award-winning team, solutions, and services have received industry praise, world-class NPS scores, and a Philadelphia Biz Journal Best Places to Work award. For more information on RetireeFirst’s people-centric approach, our services, and our broker, consultant, or carrier programs, visit retireefirst.com and follow RetireeFirst on LinkedIn and Twitter.

About Entrepreneur of the Year®

Entrepreneur of the Year® is the world’s most prestigious business awards program for unstoppable entrepreneurs. These visionary leaders deliver innovation, growth and prosperity that transform our world. The program engages entrepreneurs with insights and experiences that foster growth. It connects them with their peers to strengthen entrepreneurship around the world. Entrepreneur of the Year is the first and only truly global awards program of its kind. It celebrates entrepreneurs through regional and national awards programs in more than 145 cities in over 60 countries. National Overall Award winners go on to compete for the EY World Entrepreneur of the Year™ title. Visit ey.com/us/eoy.

Share article on social media or email:

Harris Teeter to Host Drug Take-Back Event on April 22 at several Charlotte-area stores


Harris Teeter will host a drug take-back event at four of its Charlotte locations from 10 a.m. – 2 p.m. on Saturday, April 22, 2023, as part of the U.S. Drug Enforcement Administration’s National Prescription Drug Take-Back Day. These events will provide a safe, convenient and anonymous way for local residents to dispose of unused or expired medications.


  • April 22, 2023 – 10 a.m. – 2 p.m.
  • – Davis Lake – 8445 Davis Lake Parkway, Charlotte, N.C.
  • – Stonecrest – 7852 Rea Road, Charlotte, N.C.
  • – Morrocroft Village – 6701 Morrison Boulevard, Charlotte, N.C.
  • – Smith Farm Road – 4701 Smith Farm Road, Charlotte, N.C.

Harris Teeter has partnered with SAFE KIDS and local law enforcement to assist with the event, which provides Mecklenburg County residents a opportunity to properly dispose of old, unused, or outdated prescription medication in an environmentally and legally safe method. The goal is to help the police department keep medications off the street by proper disposal of prescription medications, and knowing the dangers associated with drug abuse.

You can find more information about Harris Teeter’s commitment to drug disposal solutions on our website.

Since its inception in 2010, DEA’s National Prescription Take Back Day has removed almost 17 million pounds of unneeded medications from communities across the country according to the DEA.

According to the DEA, more than seven million Americans abuse prescription drugs, according to the 2009 Substance Abuse and Mental Health Services Administration’s National Survey on Drug Use and Health. And every day, on average, 2,500 teens use them to get high for the first time, according to the Partnership for a Drug-Free America. Studies show that a majority of abused prescription drugs are obtained from family and friends, including from the home medicine cabinet.

###

About Harris Teeter: For more than 60 years, Harris Teeter, a wholly-owned subsidiary of The Kroger Co. (NYSE: KR), has enriched lives – one meal, one family, one associate, and one community at a time. Headquartered in Matthews, North Carolina, Harris Teeter employs 36,000 valued associates across more than 250 stores and 60 fuel centers in North Carolina, South Carolina, Virginia, Georgia, Maryland, Delaware, Florida, and the District of Columbia.

Share article on social media or email:

World PH Day Amplifies Global Voices United To Cure Pulmonary Hypertension


PHA’s World PH Day theme is “United to Cure PH.”

The Pulmonary Hypertension Association (PHA) joins more than 80 organizations around the world on Friday, May 5, to recognize World PH Day. World PH Day spotlights the global impact of pulmonary hypertension (PH), a rare, complex, life-threatening disease. PH has no cure and affects more than 75 million adults and children of all ethnicities globally. PH, or high blood pressure in the lungs, causes symptoms that include shortness of breath, fatigue and chest pain.

PH is often underdiagnosed, misunderstood or misdiagnosed with more common illnesses, such as asthma. While there is no cure for PH, accurate early diagnosis and access to correct treatment can improve a patient’s quality of life and life expectancy. Without treatment, the average length of survival is under three years.

PH can exist alone or in association with other conditions. In the U.S., PH is most associated with left heart disease. Other PH-associated conditions and risks include connective tissue disorders, blood clots to the lungs, HIV, sickle cell anemia, COPD, sarcoidosis and living in high altitudes. It has also been associated with methamphetamine use.

This year, PHA’s World PH Day theme is “United to Cure PH,” which aims to recognize the global strides made in improving the lives of those affected by PH and highlights the shared goal of finding a cure for the disease. PH can affect anyone regardless of age, sex, race, social or ethnic background. Although the disease is caused by different factors around the world, it affects everyone in a similar way.

“We’ve come a long way since the first therapies for PH were introduced over a decade ago. However, we still have not been able to address the underlying issues that cause PH,” says Matt Granato, PHA president and CEO. “There is much hope ahead though, since new therapies under development aim to stop the progression, or even reverse the damage caused by the disease. It’s truly been a global effort from industry, health care providers, organizations like PHA, caregivers and patients around the world to advance the knowledge and science on PH. Working jointly with a common objective, a brighter future for our community is much closer.”

PHA encourages the global PH community to share what brings them hope in our united efforts towards finding a cure for PH and to help raise awareness on social media through posts using the #WorldPHDay2023 hashtag.

Individuals can visit the World PH Day page on PHA’s website for more information about PH and to learn how they can participate in this year’s campaign. PHA’s World PH Day webpage includes a digital toolkit with educational messages, images and other social media resources. Spanish and French resources are also available.

In the U.S., to raise awareness and advocate on behalf of those with PH, PHA will host virtual legislative visits throughout May beginning on World PH Day, May 5. Advocates will meet with their legislators and ask them to protect access to affordable care by supporting the HELP Copays Act (H.R. 830); support reforms for supplemental oxygen access; and improve benefits management policies by supporting the Safe Step Act (S. 652).

PHA will offer a parallel online opportunity for the PH community to support advocacy efforts on Capitol Hill throughout May. People with PH, their caregivers and loved ones, and health care professionals can use PHA’s Advocacy Action Center to write to their legislators. The PHA email template encourages Congress to reform supplemental oxygen access, ensuring those requiring supplemental oxygen can access the most appropriate type of oxygen for their needs.

PHA will host four in-person events in May:

About the Pulmonary Hypertension Association

Headquartered in Washington, D.C., the Pulmonary Hypertension Association (PHA) is the oldest and largest nonprofit patient association dedicated to the pulmonary hypertension (PH) community. Pulmonary hypertension is a rare, chronic and life-threatening disease of the lungs for which no cure currently exists. PHA’s mission is to extend and improve the lives of those affected by PH. To achieve this mission, PHA engages people with PH and their families, caregivers, health care providers, and researchers worldwide who work together to advocate for the PH community, provide support to patients, caregivers and families, offer up- to-date education and information on PH, improve quality patient care, and fund and promote research. For more information, visit phassociation.org and phassociation.org/worldphday/ and connect with PHA on Twitter, LinkedIn, Instagram and Facebook.

Share article on social media or email:



How Remote Methods Can Deliver Stronger Evidence, Upcoming Webinar Hosted by Xtalks


Within CNS, depression has emerged as a prime candidate for the successful deployment of hybrid DCT models.

The adoption of hybrid decentralized clinical trial models is increasing in many therapeutic areas, and central nervous system (CNS) is topping the list: CNS studies represent roughly 26 percent of all DCTs conducted since 2015, according to GlobalData’s Clinical Trial Database.

Within CNS, depression has emerged as a prime candidate for the successful deployment of hybrid DCT models. In this webinar, the featured speakers will address best practices and draw from their personal experiences, highlighting both the opportunities and the challenges of conducting depression clinical trials.

The convenience, discretion and regularity of reporting associated with remote participation can provide more accurate clinical outcomes while reducing burden on patients. A small, but growing, body of evidence also points to decentralized trials’ facilitation of more truthful self-reporting on suicidality, which — when combined with remote patient monitoring — can make this method a potentially safer option for patients.

Yet many questions remain unanswered: How can study teams ensure that patients are being properly recruited, screened and consented into a decentralized study? How can remote participation be designed to benefit depression patients without jeopardizing data quality? Are the validated instruments commonly used in depression trials suitable for decentralized data collection? How is the placebo effect accounted for in decentralized study designs?

Register now to learn more about delivering stronger evidence in depression clinical trials.

Join Taylor Major, MBA MPH, Senior Implementation Project Manager, ObvioHealth; Jenny Ly, PhD, Senior Clinical Scientist, SPRIM Consultancy; and Faith Matcham, PhD, CPsychol, Health Psychologist and Lecturer in Clinical Psychology, University of Sussex, UK, for the live webinar on Tuesday, May 9, 2023, at 10am EDT (4pm CEST/EU-Central).

For more information, or to register for this event, visit Depression Clinical Trials: How Remote Methods Can Deliver Stronger Evidence.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Direct-to-Phase II SBIR Grant from NIH Awarded to Neurexis Therapeutics to Evaluate Neuroprotective Therapeutic in Stroke Preclinical Assessment Network (SPAN)


“This is especially critical given the lack of an FDA-approved neuroprotective drug to address the devastating impacts that stroke can have on patients.” said Dr. Olivia Asfaha, Co-Principal Investigator on the grant.

Neurexis Therapeutics, Incorporated, announces it has been awarded $900,000 in funding from a Direct-to-Phase II Small Business Innovation Research (SBIR) grant through the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health. The grant will enable late-stage preclinical study of the Company’s neuroprotective peptide tatCN19o by the Stroke Preclinical Assessment Network (SPAN), which was established to address a significant need in the scientific investigation of stroke treatment. The goal of SPAN is to screen and select highly promising treatment candidates for possible further study in human clinical trials. A total of five putative cerebroprotective interventions will be tested in SPAN. With this funding, Neurexis becomes one of only two small business companies that are members of the SPAN program.

Neurexis was formed in early 2020 based on the efforts of Dr. Ulli Bayer at the University of Colorado Anschutz Medical Campus to create an optimized neuroprotective drug called tatCN19o. In both small and large animal studies, the therapeutic prevents neuronal cell death and the associated cognitive and behavioral problems resulting from ischemia caused by stroke or cardiac arrest.

“Neurexis Therapeutics considers the reliability and reproducibility of preclinical data to be of the utmost importance in drug development. Thus, we are thrilled to be part of SPAN 2.0 for continued external validation of our lead therapeutic tatCN19o,” said Dr. Olivia Asfaha, Co-Principal Investigator on the grant. “This program will use high-powered, unbiased testing to conduct direct comparison studies of tatCN19o and other stroke interventions to help expand the very limited clinical toolbox available to physicians and patients for treatment of stroke. This is especially critical given the lack of an FDA-approved neuroprotective drug to address the devastating impacts that stroke can have on patients.”

The award is funded by NINDS of the NIH under grant number U44NS132339.

About Neurexis Therapeutics, Inc.

Stroke and cardiac arrest affect millions of patients each year. Although lifesaving, re-establishing blood flow to the brain does not address the substantial impact on quality of life and healthcare costs associated with the resulting neuronal death and cognitive impairment. At this time, there are no FDA-approved drugs for this indication, resulting in a tremendous unmet medical need for a product such as tatCN19o that significantly reduces brain damage from stroke. To learn more, visit neurexistherapeutics.com.

Share article on social media or email:

Divorce With Dignity is Pleased to Announce Its Newest Affiliate


Today, Divorce With Dignity Network, Inc., the leader in helping legal professionals across the United States own and operate a successful, peaceful divorce services business, announced Dr. Shilpa Kapoor, Psy.D. as its newest Divorce With Dignity Network Affiliate in Contra Costa County, CA.

Founder and President of Divorce With Dignity Network, Inc., Cindy Elwell said, “We are delighted to welcome Shilpa as our newest affiliate to our Divorce With Dignity family. Shilpa brings with her 4 years of experience in mediation and will help couples and families peacefully divorce in and around Contra Costa County.”

Dr. Kapoor commented, “I am thrilled to be part of the Divorce with Dignity network in Contra Costa County, CA. Over the years, through my experience as a couples and family therapist, I have seen numerous partners deciding to separate and divorce carrying the emotional baggage of resentment, anger, betrayal, sadness, and helplessness. Everyone involved can end up with lasting emotional, social, and financial damage, especially the children. My approach to divorce mediation is a collaborative process balancing the logistical and emotional aspects of separation and divorce. I provide a compassionate and supportive space where the separating partners feel more empowered to make their own decisions.”

She added, “My hope with amicable divorce services is to help my clients save time, money, and frustration during this very difficult time. This not only adds to the separating partners’ emotional wellness, but it also helps them co-parent better which has a positive impact on their children’s long-term mental and physical wellbeing.”

Dr. Kapoor speaks four languages (English, Hindi, Punjabi, and Urdu) and loves to travel and experience different cultures and foods. She also enjoys hiking and reading in her free time.

For those in the Contra Costa County area in need of divorce services, or wanting to refer a friend, please contact Dr. Shilpa Kapoor:

Divorce With Dignity-Contra Costa

2603 Camino Ramon, Ste 200

San Ramon, CA 94583

Phone: (925) 222-5442

Email: skapoor@dwdignity.com

For more information on the option of peaceful divorce, you can visit the Divorce With Dignity website. There is a wealth of information about divorce on their peaceful divorce blog. You can also find a Divorce With Dignity Network Affiliate in your area.

If you are a legal professional, paralegal, attorney, or mediation firm, that would like to learn more about becoming a Divorce With Dignity Affiliate to own and operate your own peaceful divorce services business, please contact Cindy Elwell at 510-967-1735 or visit the Divorce With Dignity website.

About Divorce With Dignity Network, Inc.

The Divorce With Dignity Network, Inc. helps legal professionals across the United States to own and operate a successful peaceful divorce services business. The Divorce With Dignity Network offers a proven method and a superior lifestyle opportunity for those legal professionals seeking their own independent business or it can create a new value-add and incremental revenue stream to existing family law or mediation practices. The Divorce With Dignity Network, Inc. began licensing its peaceful divorce services business model in 2008.

Press Contact:

Cindy Elwell

President

Divorce With Dignity Network, Inc.

Sonoma, CA

Phone 510-967-1735

celwell@dwdignity.com

Share article on social media or email:

Done. rolls out largest technology-driven national platform for holistic in-person and virtual chronic psychiatric care


News Image

An industry first, Done. has reimagined today’s mental-health solutions with a revolutionary hybrid platform designed to tackle psychiatric care. Through an innovative and holistic approach, Done. now allows anyone to tap into the best of both virtual and in-person treatments to better help patients and clinicians achieve better clinical outcomes.

The new platform combines 200+ in-person offices through a blended use of trusted clinical partnerships and virtual care. As a result, Done. now meets patients whenever and wherever they are to deliver world-class psychiatric care nationwide. Hybrid care is defined as a combination of in-person with virtual coverage to provide a holistic option for the patient and provider to achieve the greatest clinical outcomes possible. Done. achieves this fusion of coverage through a “direct” and collaborative care model. It merges Done.’s ongoing virtual care experience with high-touch in-person care conducted by Done.’s clinician consultations at Done. offices, through partner clinician in-person consultations, and via trusted provider referrals to distribute access to the best psychiatric care available.

Done’s mission has always been to empower and support our members in reaching their potential. We started Done because there was a lack of qualified clinicians to treat patients and because patients struggled to access care within their communities. As the Biden administration announced on January 30, 2023, the COVID-19 public-health emergency (PHE) will end on May 11, 2023.

Based on the updated regulation, the Done. team has now adapted to meet the needs of how society has shifted by providing a combination of in-person and virtual care. In 2020, given the velocity of patient demand as well as the need to accommodate regulations for virtual care licensing and prescribing, the physical and economic barriers to access, particularly in underserved communities, were eliminated. Now, post-pandemic, and given our original mission to meet patients when and where they are, we are doing just that – offering the best in both in-person and virtual care through Done. offices and partnerships to serve patients with holistic psychiatric care that goes beyond ADHD treatment. As the means to distribute care shifts, so, too, is the nature of the treatment. Done. first committed to better access and efficiency for ADHD care.

Today, we’ve built a technology platform that sets a higher standard for patient care, and while we believe that our specialization in ADHD allows us to achieve better clinical outcomes and safer patient care, we are now ready to expand into a holistic approach that focuses on a wider range of psychiatric challenges.

Working in tandem with in-person medical practitioners, the Done. platform arms clinicians with deeper data and insights to ensure accurate diagnoses and allow monitoring of patient use of prescribed drugs to ensure proper dosage and mitigate potential abuse. The Done. platform leads the way to encapsulate how technology can improve the quality and effectiveness of healthcare services to make life better for patients.

As Done. scales our hybrid model nationally to all members, we are taking all necessary precautions to ensure a smooth transition for our patients and will keep them informed throughout the process. To learn more about the platform, visit DoneFirst.com.

About Done.

Done. is a hybrid-care (in-person + virtual) health platform that empowers anyone living with mental health challenges to reach their fullest potential. Through a patient-first, technology-powered platform, industry-leading digital-health company, Done. makes high-quality psychiatric chronic care management more accessible and affordable. Disclaimer: Done. is an online platform that connects members with qualified clinicians to screen, diagnose, and treat members with ADHD. Done. does not provide medical services. All professional services on the Done. platform are provided by clinicians who are psychiatric board-certified medical professionals;

Done. does not engage in the prescription business.

Share article on social media or email: